array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(39) "DSM Nutritional Products Nederland B.V."
["slug"]=>
string(46) "f05d1-nl-dsm-nutritional-products-nederland-bv"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/7623249b-0a8f-4493-a572-52677680a3a0"
["description"]=>
string(816) "DSM, since May 9 2023 part of dsm-firmenich, is a global, purpose-led leader in health and nutrition, applying bioscience to improve the health of people, animals, and the planet. DSM’s purpose is to create brighter lives for all which we achieve through developing products and solutions that address some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value.
From our master perfumers and flavorists to our expert nutritionists and scientists, our trailblazing teams work closely with customers, supporting their ambitions with 150+ years of R&D expertise.
With a passionate and talented team of close to 30,000 employees, we are determined to be a force for good. And to work together to positively impact people and planet.
#webringprogresstolife "
["address_street"]=>
string(11) "Columbusweg"
["address_place"]=>
string(5) "Venlo"
["address_region"]=>
string(7) "Limburg"
["founding_date"]=>
string(10) "2001-03-29"
["website_domain"]=>
string(7) "dsm.com"
["website_url"]=>
string(19) "https://www.dsm.com"
["industry_codes"]=>
array(1) {
[0]=>
string(27) "Pharmaceutical Preparations"
}
["employee_count"]=>
int(56)
["article_count"]=>
int(412)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(31) "Sales of Botox soared in Russia"
["snippet_en"]=>
string(222) "In the first quarter of 2024, Russian pharmacies sharply increased sales of botulinum toxin drugs. In monetary terms they grew by 123 percent, to 46.8 million rubles, and in physical terms - by 139 percent, to 4,817 packs."
["url"]=>
string(39) "https://lenta.ru/news/2024/04/25/botox/"
["image_url"]=>
NULL
["source"]=>
string(8) "lenta.ru"
["publication_date"]=>
string(10) "2024-04-02"
["categories"]=>
array(1) {
[0]=>
string(24) "Quarterly/Annual Figures"
}
}
[1]=>
array(7) {
["title_en"]=>
string(25) "How are patients treated?"
["snippet_en"]=>
string(74) "DSM Group presented an annual report on the Russian pharmaceutical market."
["url"]=>
string(73) "https://www.vedomosti.ru/press_releases/2024/04/02/chem-lechat-patsientov"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/9a1d713d-efe8-45fb-b8df-ca9445ed1a29"
["source"]=>
string(12) "vedomosti.ru"
["publication_date"]=>
string(10) "2024-04-02"
["categories"]=>
array(1) {
[0]=>
string(24) "Quarterly/Annual Figures"
}
}
[2]=>
array(7) {
["title_en"]=>
string(87) ""Volumes impacted by lower ingredient sales". DSM-Firmenich AG sees sales decline in Q2"
["snippet_en"]=>
string(168) "In the first financial results call since its merger, fragrance and flavours company DSM-Firmenich AG presented its half-year and Q2 sales results on a pro forma basis."
["url"]=>
string(144) "https://www.cosmeticsdesign-europe.com/Article/2023/08/09/Volumes-impacted-by-lower-ingredient-sales-.-DSM-Firmenich-AG-sees-sales-decline-in-Q2"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/9e83da4d-bfb8-4722-ac2d-919ac6d78821"
["source"]=>
string(26) "cosmeticsdesign-europe.com"
["publication_date"]=>
string(10) "2023-08-09"
["categories"]=>
array(2) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[3]=>
array(7) {
["title_en"]=>
string(91) "Shortly after the merger: DSM-Firmenich is struggling with problems in the vitamin business"
["snippet_en"]=>
string(139) "DSM Firmenich has issued a negative report. According to the forecast, the operating result for 2023 will deteriorate by 400 million euros."
["url"]=>
string(123) "https://www.handelszeitung.ch/unternehmen/kurz-nach-der-fusion-dsm-firmenich-kampft-mit-problemen-im-vitamingeschaft-614990"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/07096f17-258b-444e-90d9-98efa406a785"
["source"]=>
string(17) "handelszeitung.ch"
["publication_date"]=>
string(10) "2023-06-28"
["categories"]=>
array(3) {
[0]=>
string(6) "Merger"
[1]=>
string(24) "Quarterly/Annual Figures"
[2]=>
string(18) "Ecological Impacts"
}
}
[4]=>
array(7) {
["title_en"]=>
string(87) "STOCKS IN FOCUS 2: Symrise shakes off share price burden due to antitrust investigation"
["snippet_en"]=>
string(206) "(new: closing prices, Credit Suisse, Baader Bank) FRANKFURT (dpa-AFX) - The shares of the fragrance and flavors manufacturer Symrise were able to make up for their losses by the end of trading on Wednesday."
["url"]=>
string(144) "https://www.finanznachrichten.de/nachrichten-2023-03/58504679-aktien-im-fokus-2-symrise-schuetteln-kurslast-durch-kartelluntersuchung-ab-016.htm"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/a30fe409-27bc-44ec-a774-28325eee8cee"
["source"]=>
string(20) "finanznachrichten.de"
["publication_date"]=>
string(10) "2023-03-08"
["categories"]=>
array(9) {
[0]=>
string(6) "Merger"
[1]=>
string(14) "Issuing Shares"
[2]=>
string(12) "Stock Market"
[3]=>
string(14) "Product Launch"
[4]=>
string(24) "Quarterly/Annual Figures"
[5]=>
string(18) "General Investment"
[6]=>
string(31) "Financial Update/Profit Warning"
[7]=>
string(9) "Antitrust"
[8]=>
string(19) "Under Investigation"
}
}
[5]=>
array(7) {
["title_en"]=>
string(34) "Significant decline in DSM profits"
["snippet_en"]=>
string(80) "DSM saw its turnover and profit decline last quarter compared to a year earlier."
["url"]=>
string(69) "https://www.rtl.nl/geld-en-werk/artikel/1727576/forse-winstdaling-dsm"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/661a8357-91d3-42b0-84cb-a3931496b1b4"
["source"]=>
string(6) "rtl.nl"
["publication_date"]=>
string(10) "2014-08-05"
["categories"]=>
array(2) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[6]=>
array(7) {
["title_en"]=>
string(38) "DSM: Plastics businesses are improving"
["snippet_en"]=>
string(112) "The plastics business in particular improved the results of the chemical group DSM in the third quarter of 2009."
["url"]=>
string(99) "https://www.kunststoffweb.de/branchen-news/dsm_kunststoffgeschaefte_zeigen_sich_verbessert_t214789/"
["image_url"]=>
NULL
["source"]=>
string(16) "kunststoffweb.de"
["publication_date"]=>
string(10) "2009-11-17"
["categories"]=>
array(5) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(31) "Financial Update/Profit Warning"
[3]=>
string(20) "Business Development"
[4]=>
string(33) "Materials Sourcing and Efficiency"
}
}
[7]=>
array(7) {
["title_en"]=>
string(68) "Sales of Botox and analogues in Russia increased by 123% - Vedomosti"
["snippet_en"]=>
string(204) "Russian pharmacies earned 104.4 million rubles from the sale of botulinum toxin drugs in the first quarter of 2024, that is, 123% more than a year earlier, Vedomosti writes, citing a report from DSM Group"
["url"]=>
string(29) "https://theins.ru/news/271099"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/a7fec543-7b23-4984-96f5-7c1a94271e44"
["source"]=>
string(9) "theins.ru"
["publication_date"]=>
NULL
["categories"]=>
array(1) {
[0]=>
string(24) "Quarterly/Annual Figures"
}
}
[8]=>
array(7) {
["title_en"]=>
string(69) "Demand for Botox has soared in Russia – its sales increased by 123%"
["snippet_en"]=>
string(221) "In the first quarter of 2024, Russian pharmacies earned 104.4 million rubles from the sale of 11.5 thousand packages of botulinum toxin drugs, while last year they sold 4.8 thousand units and received 46.8 million rubles."
["url"]=>
string(41) "https://www.business-gazeta.ru/amp/631148"
["image_url"]=>
NULL
["source"]=>
string(18) "business-gazeta.ru"
["publication_date"]=>
NULL
["categories"]=>
array(1) {
[0]=>
string(24) "Quarterly/Annual Figures"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(22)
}
[1]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(18)
}
[2]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(16)
}
[3]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(15)
}
[4]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(14)
}
[5]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(13)
}
[6]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(12)
}
[7]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(12)
}
[8]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(10)
}
[9]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(10)
}
[10]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(9)
}
[11]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(9)
}
[12]=>
array(2) {
["name"]=>
string(22) "Sustainable Investment"
["count"]=>
int(9)
}
[13]=>
array(2) {
["name"]=>
string(19) "Green & Responsible"
["count"]=>
int(8)
}
[14]=>
array(2) {
["name"]=>
string(17) "Energy Management"
["count"]=>
int(8)
}
[15]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(8)
}
[16]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(8)
}
[17]=>
array(2) {
["name"]=>
string(33) "Materials Sourcing and Efficiency"
["count"]=>
int(8)
}
[18]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(7)
}
[19]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(6)
}
[20]=>
array(2) {
["name"]=>
string(13) "GHG Emissions"
["count"]=>
int(6)
}
[21]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(6)
}
[22]=>
array(2) {
["name"]=>
string(24) "Employee Health & Safety"
["count"]=>
int(5)
}
[23]=>
array(2) {
["name"]=>
string(6) "Energy"
["count"]=>
int(5)
}
[24]=>
array(2) {
["name"]=>
string(13) "Raw Materials"
["count"]=>
int(5)
}
[25]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(5)
}
[26]=>
array(2) {
["name"]=>
string(20) "Alternative Energies"
["count"]=>
int(4)
}
[27]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(4)
}
[28]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(4)
}
[29]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(4)
}
}
}
f05d1-nl-dsm-nutritional-products-nederland-bv
DSM Nutritional Products Nederland B.V.
Location
Limburg
Founded
2001-03-29
Website
https://www.dsm.com
Articles
412 Articles
Category
Pharmaceutical Preparations
Description
DSM, since May 9 2023 part of dsm-firmenich, is a global, purpose-led leader in health and nutrition, applying bioscience to improve the health of people, animals, and the planet. DSM’s purpose is to create brighter lives for all which we achieve through developing products and solutions that address some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value.
From our master perfumers and flavorists to our expert nutritionists and scientists, our trailblazing teams work closely with customers, supporting their ambitions with 150+ years of R&D expertise.
With a passionate and talented team of close to 30,000 employees, we are determined to be a force for good. And to work together to positively impact people and planet.
#webringprogresstolife
In the first quarter of 2024, Russian pharmacies sharply increased sales of botulinum toxin drugs. In monetary terms they grew by 123 percent, to 46.8 million rubles, and in physical terms - by 139 percent, to 4,817 packs.
In the first financial results call since its merger, fragrance and flavours company DSM-Firmenich AG presented its half-year and Q2 sales results on a pro forma basis.
(new: closing prices, Credit Suisse, Baader Bank) FRANKFURT (dpa-AFX) - The shares of the fragrance and flavors manufacturer Symrise were able to make up for their losses by the end of trading on Wednesday.
Russian pharmacies earned 104.4 million rubles from the sale of botulinum toxin drugs in the first quarter of 2024, that is, 123% more than a year earlier, Vedomosti writes, citing a report from DSM Group
In the first quarter of 2024, Russian pharmacies earned 104.4 million rubles from the sale of 11.5 thousand packages of botulinum toxin drugs, while last year they sold 4.8 thousand units and received 46.8 million rubles.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
